AI beats doctors: OpenAI’s o1-preview outperformed physicians in multiple diagnostic and reasoning benchmarks, especially in early emergency department triage. Caution urged: Experts warn that high ...

The rising prevalence of diseases in both developed and developing nations highlights the need to explore new pharmaceutical ...

Researchers from Stanford University and Rensselaer Polytechnic Institute have developed an advanced AI model that improves the prediction accuracy of clinical trial approvals. The study, published in ...

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Clinical trials represent a significant ...

The biosimulation market is driven by the rising complexity of drug development, increasing demand for cost-efficient R&D processes, and growing adoption of modeling and simulation tools. North ...

This article reviews the scope, key principles, methodological expectations, and regulatory implications of ICH E20, and ...

The in silico clinical trials market is poised for rapid growth, driven by the need to reduce traditional trial costs, AI adoption, regulatory support, and personalized medicine expansion. Major ...

MERIDIAN, Miss.—A Mississippi State University faculty member and undergraduate researcher are using eye-tracking technology at MSU-Meridian to study how students see, process and respond in ...

A Harvard-led study found a large language model matched or exceeded hundreds of physicians in diagnostic and management reasoning tasks, especially in early emergency department triage. The AI ...

As sponsor needs change strategic collaboration with CDMOs/CROs is becoming more important for execution and early input.